Portugal’s lawmakers authorised sweeping modifications to how medical cannabis is regulated within the nation, which can open new alternatives for worldwide and domestic corporations.
The regulation spells out guidelines for medical cannabis cultivation, manufacturing, extraction and business manufacture, in addition to wholesale, distribution to pharmacies, import and export, transit and sale of the merchandise.
The invoice – permitted by Parliament final week – now awaits President Marcelo Rebelo de Sousa’s approval to develop into regulation.
Portugal already cultivates giant portions of medical cannabis, however the drugs has remained largely inaccessible to domestic sufferers, which put the nation in a precarious state of affairs with numerous United Nations treaties.
The National Authority of Medicines and Health Products (Infarmed) can be answerable for regulating most elements of MMJ, and all medical marijuana merchandise would require a license from the federal government company.
Medical marijuana can be obtainable solely from pharmacies with a medical practitioner’s prescription.
Doctors will probably be allowed to prescribe medical cannabis for any situation when different remedies are usually not efficient.
Dried bud and derivatives will probably be allowed, in accordance with native specialists contacted by Marijuana Business Daily.
The regulation goes into pressure July 1, however the market is predicted to be open for enterprise by the top of this yr.
Canadian corporations are already positioning themselves to capitalize.
Last yr, Infarmed accepted British Columbia-based Tilray’s 20 million euro ($22 million) medical marijuana manufacturing facility in Portugal to serve the European Union.
Infarmed first approved cannabis cultivation in 2014.
Matt Lamers might be reached at [email protected]
To join our weekly Canada marijuana enterprise publication, click on right here.